Metraipolis › archive › dc_2bdd6c45cf09

Increased Risk of Hepatitis B Virus Reactivation in Patients with Resolved Hepatitis B Virus Infection Receiving Combination Immunosuppressive Therapy: The… — Europe PMC PMID:42253249

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42253249
DOI
10.5152/tjg.2026.26167
License (as archived)
solo-consultazione
Archived
2026-10-31T20:10:21.722Z
SHA-256 of the archived text
8d03a1ff435c1a24d633600639422702b260ee43cd16a0f883676bee8da27feb
Stable URL of this page
https://metraipolis.com/documento/dc_2bdd6c45cf09

How to cite

Increased Risk of Hepatitis B Virus Reactivation in Patients with Resolved Hepatitis B Virus Infection Receiving Combination Immunosuppressive Therapy: The… — Europe PMC PMID:42253249 — Europe PMC (en), https://europepmc.org/article/MED/42253249 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bdd6c45cf09 (Metraipolis archive dc_2bdd6c45cf09, sha256 8d03a1ff435c1a24d633600639422702b260ee43cd16a0f883676bee8da27feb)
BibTeX
@misc{dc2bdd6c45cf09,
  title = {Increased Risk of Hepatitis B Virus Reactivation in Patients with Resolved Hepatitis B Virus Infection Receiving Combination Immunosuppressive Therapy: The… — Europe PMC PMID:42253249},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42253249},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bdd6c45cf09; sha256 8d03a1ff435c1a24d633600639422702b260ee43cd16a0f883676bee8da27feb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42253249. Agents can read the archived copy with the MCP tool read_document.